Publications by authors named "J E Dent"

Background: We conducted three serial cross-sectional representative surveys after a mass cholera vaccination campaign in Uvira, Democratic Republic of the Congo to (1) estimate the vaccination coverage and explore heterogeneity by geographic and demographic factors; (2) examine barriers and facilitators of vaccine uptake and (3) describe the changes in coverage over time and predict future coverage.

Methods: We collected data on sociodemographics, self-reported vaccination status, population movement and knowledge, attitudes and behaviours related to killed oral cholera vaccines (kOCVs) in August 2021, April 2022 and April 2023, approximately 11, 19 and 30 months postvaccination. We compared the characteristics of participants by vaccination status and explored the potential role of population movement as a cause for low coverage.

View Article and Find Full Text PDF

Introduction: In adults with moderate-to-severe atopic dermatitis (AD), rocatinlimab demonstrated significant and progressive improvement in clinical measures of disease severity compared with placebo. This post hoc analysis of a phase 2b study was undertaken to understand the disease burden and to assess the impact of rocatinlimab on patient-reported outcomes (PROs).

Methods: This analysis used baseline data from a multicenter, randomized, double-blind study of adults with moderate-to-severe AD, who completed a Worst Pruritus numerical rating scale (NRS), Sleep Disturbance NRS, and the Dermatology Life Quality Index (DLQI).

View Article and Find Full Text PDF
Article Synopsis
  • X-linked hypophosphatemia (XLH) is a genetic disorder that leads to significant skeletal issues and impacts physical function and work productivity in adults.
  • A study analyzed data from 281 XLH patients, revealing that many are not employed or rely on disability payments; those with fewer orthopedic surgeries and better physical function are more likely to have full-time jobs.
  • Overall, the findings indicate that XLH severely affects work productivity, with younger patients, worse pain, and higher orthopedic surgery counts linked to more demanding job roles.
View Article and Find Full Text PDF
Article Synopsis
  • - Mycosis fungoides (MF) and Sézary syndrome (SS) are skin-related lymphomas that can significantly affect quality of life (HRQL), and a study found that patients treated with mogamulizumab reported better HRQL compared to those on vorinostat.
  • - A study involving 372 adults with relapsed MF or SS revealed that their HRQL was notably lower than normal averages, particularly affecting their emotional state and functioning due to factors like itchiness and overall health.
  • - Key demographic factors such as being female, younger, and having specific health conditions were linked to worse HRQL across different assessments, emphasizing the need to address these issues in patient care.
View Article and Find Full Text PDF

Background: Digital health interventions show promise for weight management. However, few text-based behavior change interventions have been designed to support patients receiving intragastric balloons, and none have simultaneously evaluated weight loss, psychological well-being, and behavior change despite the crucial interplay of these factors in weight management.

Objective: This study aims to assess whether a health coach-led, asynchronous, text-based digital behavior change coaching intervention (DBCCI) delivered to participants receiving an intragastric balloon and its aftercare program was feasible and acceptable to participants and supported improved outcomes, including weight loss, psychological well-being, and lifestyle behavior change conducive to weight loss maintenance.

View Article and Find Full Text PDF